Merck announced on April 20 that Joseph Romanelli will join the Kenilworth-based company’s executive to lead Human Health International, effective Aug. 1.
KENILWORTH, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Joseph Romanelli will lead Human Health International, and join Merck’s Executive Team, effective August 1, 2022. He will report directly to Robert M. Davis, chief executive officer and president, Merck.